Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAMOXIFEN vs TARLATAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TAMOXIFEN vs TARLATAMAB: Safety Overview

Metric TAMOXIFEN TARLATAMAB
Total FAERS Reports 9,105 145
Deaths Reported 811 49
Death Rate 8.9% 33.8%
Hospitalizations 1,754 52
Average Patient Age 55.6 yrs 62.7 yrs
% Female Patients 95.6% 34.0%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Dr. Reddy's Labratories Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A